🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Fast and accurate platelet inhibition is an important therapeutic goal in t...
Status
Completed
Location
Isala clinics
Start Date
2018-02-16
Trial ID
NCT03400267
Treatments Being Tested
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Start Date
TBD
Trial ID
NCT02541643
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of sin...
Status
Completed
Location
Anapharm
Start Date
2008-07
Trial ID
NCT00734240
Patent ductus arteriosus (PDA) is a common problem in preterm babies. Recen...
Status
Completed
Location
Post Graduate Institute of Medical Education and Research
Start Date
2016-03
Trial ID
NCT03022253
Treatments Being Tested
The purpose of the research is to investigate the effect of preoperative Cr...
Status
Recruiting
Location
Virtua Orthopedics Burlington
Start Date
2024-08-28
Trial ID
NCT06603051
Treatments Being Tested
This study aims to assess the outcome of standardized evidence-based care t...
Status
Completed
Location
Zagazig University Faculty of Human Medicine
Start Date
2017-05-15
Trial ID
NCT04615702
Treatments Being Tested
A study in healthy male and female participants of non-childbearing potenti...
Status
Completed
Location
Research Site
Start Date
2022-09-20
Trial ID
NCT05511025
Treatments Being Tested
The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Start Date
2024-06-11
Trial ID
NCT06305754